Concepedia

Publication | Open Access

Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer

DOIFull Paper Access

12

Citations

33

References

2023

Year

Tairo Kashihara, Yuko Nakayama, Kae Okuma, Ayaka Takahashi, Tomoya Kaneda, Mika Katagiri, Hiroki Nakayama, Yuko Kubo, Kimiteru Ito, Satoshi Nakamura,
Radiotherapy and Oncology

Abstract

Pretreatment ILA, adenocarcinoma, and performance status may have an impact on OS of LA-NSCLC patients receiving CCRT plus durvalumab.

References

YearCitations

Page 1